Microbial Testing Market

The global microbial testing market size was valued USD 3.9 billion in 2020 and is projected to reach USD 5.3 billion by 2028 at a CAGR of 6.5% during the forecast period, 2021-2028. The growth of the market is attributed to rising incidence of infectious diseases such as HIV, human papillomavirus (HPV), and hepatitis B and C.

Several emerging molecular diagnostic techniques are being used more frequently for early detection and effective treatment of pathogen-borne diseases. When compared to traditional laboratory techniques, advanced molecular diagnostic techniques provide several technological advantages such as faster turnaround time, high sample throughput, multiplexing of reactions, specificity, improved accuracy, and increased device sensitivity. NGS, real-time PCR, molecular cartridges, and PCR coupled with mass spectrometry are among the advanced molecular diagnostic techniques that are increasingly becoming acknowledged for their ability to identify and characterize various pathogens as well as analyze samples in a single run.

Get Free Sample Report

Market Trends, Drivers, Restraints, and Opportunities

• Technological advancements in microbiology testing is anticipated to drive the market growth.
• The outbreaks of epidemics such as COVID 19 and rising healthcare expenditure are expected to foster the growth of the market/
•  Rising private-public funding for infectious disease research are driving the growth of the microbiology testing market.
• The presence of robust medical infrastructure, such as hospitals and clinical labs in emerging economies and low-income countries is estimated to propel the market growth.
• High cost of tests can create challenges for the growth of the market in the projected timeline.
• Rising geriatric population and increasing clinical research in clinical microbiology are anticipated to proliferate the growth of the market during the forecast period.

Scope of Microbial Testing Market Report

The report on the global microbial testing market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Microbial Testing Market Segment Insights

Instruments segment to account a major market share

Based on types, the market is divided into instruments and reagents. The instruments segment to hold a large market share in the projected timeline. Microbiology equipment is a broad category that encompasses a wide range of instruments used in microbiology labs. Microscopes, slides, test tubes, petri dishes, solid and liquid growth mediums, inoculation loops, pipettes and tips, incubators, autoclaves, and laminar flow hoods are few examples of microbiology equipment.

A reagent is a material or ingredient that is added to a system to either produce or test a chemical reaction. The reactants are usually referred to as substrates in biochemistry, especially when enzyme-catalyzed reactions are involved. The reagent segment is anticipated to grow at a robust rate during the forecast period.

Get Free Sample Report

Pharmaceutical segment to hold a major market share

On the basis of applications, the microbial testing market is segregated into pharmaceutical, clinical, food testing, energy, chemical and material manufacturing, and environment. The pharmaceutical segment is expected to dominate the market. The presence of well-established and acknowledgments of rules that control the evaluation of microbiological contamination during pharmaceutical manufacturing and raw material sourcing are largely responsible for this segment's substantial share. To assure sanitization, several regulatory authorities such WHO, FDA, and the Medicines and Healthcare Products Regulatory Agency (MHRA, UK)] have well-defined regulatory criteria for the evaluation of microbiological contamination in excipients and APIs.

North America is projected to hold a major market share

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominated the market in 2020, in terms of revenue. Clinical microbiology technologies are widely used among key end-users such as hospitals, diagnostic centers, research laboratories, and commercial service providers in North America, which has well-established distribution channels for clinical microbiology product manufacturers and suppliers. The high adoption of modern diagnostic technologies, as well as supporting government policies in the US and Canada are further driving the growth of the market in the region.

Get Free Sample Report

Segments

The global microbial testing market is segmented on the basis of

Types

• Instruments
• Reagents

End-users

• Pharmaceutical
• Clinical
• Food Testing
• Energy
• Chemical
• Material Manufacturing
• Environment

Regions

• Asia Pacific
• North America
• Latin America
• Europe
• Middle East & Africa

Key Players

• Quidel Corporation
• F. Hoffmann-La Roche Ltd.
• Dickinson and Company
• Thermo-Fischer Scientific, Inc.
• Gen-Probe
• Danaher

Competitive Landscape

The major players in the microbial testing market include Quidel Corporation, Dickinson and Company, F. Hoffmann-La Roche Ltd., Thermo-Fischer Scientific, Inc., Gen-Probe and Danaher.

Companies are engaging in mergers, acquisitions and partnerships to expand their market share. Danaher is a well-known name in the field of clinical microbiology. Beckman Coulter and Cepheid, the company's wholly-owned subsidiaries, operate in the clinical microbiology testing sector. Danaher is primarily focusing on leveraging its market position in the global microbiology/clinical testing market through acquisitions and product releases.